A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Clinical trial NCT00938158 · COMPLETED

Trial details

NCT number: NCT00938158
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-08-05
Primary completion: 2011-04-12
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.